BalchemvsCRH

BCPC and CRH stock compared: price, dividend, valuation and results, from SEC filings.

Balchem (BCPC) has a market value of $5.4B and CRH (CRH) $61.9B. Over the last year, with dividends, BCPC moved +9.2% and CRH -13.9%. The P/E is 31.6 for BCPC and 17.4 for CRH. Dividend yield: BCPC none, CRH 1.69%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BCPC$5.4B

    CRH$61.9B

    CRH is 11 times BCPC

  • Revenue, 12 months

    BCPC$1.1B

    CRH$39.0B

    CRH is 35 times BCPC

  • Net income, 12 months

    BCPC$171M

    CRH$3.6B

    CRH is 21 times BCPC

  • Operating margin

    BCPC20.7%

    CRH13.7%

    7.0 points apart

  • ROIC

    BCPC13.8%

    CRH9.2%

    4.6 points apart

  • P/E

    BCPC31.6

    CRH17.4

    BCPC is 1.8 times CRH

  • Dividend yield

    BCPC0.0%

    CRH1.7%

    1.7 points apart

  • 5-year return

    BCPC+3.4%

    CRH+109.9%

    106.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BCPC+3.4%

CRH+109.9%

10020020222023202420252026
Returns by period
PeriodBCPCWith dividendsCRHWith dividends
1 year since November 17, 2025+9.2%Price +8.5%-13.9%Price -15.3%
3 years since November 17, 2023+40.1%+11.9% a yearPrice +37.8%+62.5%+17.6% a yearPrice +53.8%
5 years since November 17, 2021+3.4%+0.7% a yearPrice +0.7%+109.9%+16.0% a yearPrice +83.7%
10 years since November 18, 2016+126.9%+8.5% a yearPrice +115.2%+256.5%+13.6% a yearPrice +174.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BCPCBalchemCRHCRH

Valuation

BCPCCRH
Valuation
Price$168.73$92.58
Market value$5.4B$61.9B
Enterprise value (EV)$5.5B$77.0B
P/E31.617.4
P/E, 5-year median41.516.0
P/B4.12.5
EV/EBIT23.814.4
Free cash flow yield3.3%4.1%

Results and growth

BCPCCRH
Results and growth
Revenue, 12 months$1.1B$39.0B
Net income, 12 months$171M$3.6B
Free cash flow, 12 months$178M$2.5B
Earnings per share, 12 months$5.31$5.32
Revenue growth, year on year8.8%5.3%
Revenue growth a year, past+8.1%over 5 years+7.7%over 5 years
EPS growth a year, past+12.8%over 5 years-47.8%over 5 years

Margins and returns on capital

BCPCCRH
Margins and returns on capital
Gross margin36.5%36.2%
Operating margin20.7%13.7%
Net margin15.4%9.2%
ROIC13.8%9.2%
ROE13.2%15.0%

Balance sheet

BCPCCRH
Balance sheet
Cash$66M$5.1B
Total debt$142M$21.6B
Net debt / EBITDA0.22.0
Interest cover–6.3×

Dividends and buybacks

BCPCCRH
Dividends and buybacks
Dividend yield–1.7%
Dividend per share, 12 months–$1.56
Dividend growth a year, past+11.1%over 5 years–
Buyback yield2.0%1.9%
Shareholder yield2.0%3.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BCPC or CRH

Didn't find what you were looking for?

Ask us
Which is bigger, Balchem or CRH?

By market value, CRH ($61.9B) is about 11.4 times Balchem ($5.4B), at today's prices.

How did BCPC and CRH stock do over the last 10 years?

Since November 18, 2016, BCPC's price moved +115.2% and CRH's +174.5%. With dividends: BCPC +126.9% (+8.5% a year), CRH +256.5% (+13.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, BCPC or CRH?

The dividend yield at today's price is none for Balchem and 1.69% for CRH. Over the last twelve months they paid – and $1.56 per share.

What is the P/E of BCPC and CRH?

At today's price, the P/E is 31.6 for BCPC and 17.4 for CRH. The median of the last five years was 41.5 and 16.0, which shows where each stands against its own past.

Which has the higher profit margins, Balchem or CRH?

Over the last twelve months, the net margin was 15.4% for Balchem and 9.2% for CRH, and the operating margin 20.7% and 13.7%. Revenue was $1.1B and $39.0B.

Which is the better investment, Balchem or CRH?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.